Cargando…

Infectious Threats, the Intestinal Barrier, and Its Trojan Horse: Dysbiosis

The ecosystem of the gut microbiota consists of diverse intestinal species with multiple metabolic and immunologic activities and it is closely connected with the intestinal epithelia and mucosal immune response, with which it builds a complex barrier against intestinal pathogenic bacteria. The micr...

Descripción completa

Detalles Bibliográficos
Autores principales: Iacob, Simona, Iacob, Diana Gabriela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6692454/
https://www.ncbi.nlm.nih.gov/pubmed/31447793
http://dx.doi.org/10.3389/fmicb.2019.01676
_version_ 1783443556394860544
author Iacob, Simona
Iacob, Diana Gabriela
author_facet Iacob, Simona
Iacob, Diana Gabriela
author_sort Iacob, Simona
collection PubMed
description The ecosystem of the gut microbiota consists of diverse intestinal species with multiple metabolic and immunologic activities and it is closely connected with the intestinal epithelia and mucosal immune response, with which it builds a complex barrier against intestinal pathogenic bacteria. The microbiota ensures the integrity of the gut barrier through multiple mechanisms, either by releasing antibacterial molecules (bacteriocins) and anti-inflammatory short-chain fatty acids or by activating essential cell receptors for the immune response. Experimental studies have confirmed the role of the intestinal microbiota in the epigenetic modulation of the gut barrier through posttranslational histone modifications and regulatory mechanisms induced by epithelial miRNA in the epithelial lumen. Any quantitative or functional changes of the intestinal microbiota, referred to as dysbiosis, alter the immune response, decrease epithelial permeability and destabilize intestinal homeostasis. Consequently, the overgrowth of pathobionts (Staphylococcus, Pseudomonas, and Escherichia coli) favors intestinal translocations with Gram negative bacteria or their endotoxins and could trigger sepsis, septic shock, secondary peritonitis, or various intestinal infections. Intestinal infections also induce epithelial lesions and perpetuate the risk of bacterial translocation and dysbiosis through epithelial ischemia and pro-inflammatory cytokines. Furthermore, the decline of protective anaerobic bacteria (Bifidobacterium and Lactobacillus) and inadequate release of immune modulators (such as butyrate) affects the release of antimicrobial peptides, de-represses microbial virulence factors and alters the innate immune response. As a result, intestinal germs modulate liver pathology and represent a common etiology of infections in HIV immunosuppressed patients. Antibiotic and antiretroviral treatments also promote intestinal dysbiosis, followed by the selection of resistant germs which could later become a source of infections. The current article addresses the strong correlations between the intestinal barrier and the microbiota and discusses the role of dysbiosis in destabilizing the intestinal barrier and promoting infectious diseases.
format Online
Article
Text
id pubmed-6692454
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-66924542019-08-23 Infectious Threats, the Intestinal Barrier, and Its Trojan Horse: Dysbiosis Iacob, Simona Iacob, Diana Gabriela Front Microbiol Microbiology The ecosystem of the gut microbiota consists of diverse intestinal species with multiple metabolic and immunologic activities and it is closely connected with the intestinal epithelia and mucosal immune response, with which it builds a complex barrier against intestinal pathogenic bacteria. The microbiota ensures the integrity of the gut barrier through multiple mechanisms, either by releasing antibacterial molecules (bacteriocins) and anti-inflammatory short-chain fatty acids or by activating essential cell receptors for the immune response. Experimental studies have confirmed the role of the intestinal microbiota in the epigenetic modulation of the gut barrier through posttranslational histone modifications and regulatory mechanisms induced by epithelial miRNA in the epithelial lumen. Any quantitative or functional changes of the intestinal microbiota, referred to as dysbiosis, alter the immune response, decrease epithelial permeability and destabilize intestinal homeostasis. Consequently, the overgrowth of pathobionts (Staphylococcus, Pseudomonas, and Escherichia coli) favors intestinal translocations with Gram negative bacteria or their endotoxins and could trigger sepsis, septic shock, secondary peritonitis, or various intestinal infections. Intestinal infections also induce epithelial lesions and perpetuate the risk of bacterial translocation and dysbiosis through epithelial ischemia and pro-inflammatory cytokines. Furthermore, the decline of protective anaerobic bacteria (Bifidobacterium and Lactobacillus) and inadequate release of immune modulators (such as butyrate) affects the release of antimicrobial peptides, de-represses microbial virulence factors and alters the innate immune response. As a result, intestinal germs modulate liver pathology and represent a common etiology of infections in HIV immunosuppressed patients. Antibiotic and antiretroviral treatments also promote intestinal dysbiosis, followed by the selection of resistant germs which could later become a source of infections. The current article addresses the strong correlations between the intestinal barrier and the microbiota and discusses the role of dysbiosis in destabilizing the intestinal barrier and promoting infectious diseases. Frontiers Media S.A. 2019-08-07 /pmc/articles/PMC6692454/ /pubmed/31447793 http://dx.doi.org/10.3389/fmicb.2019.01676 Text en Copyright © 2019 Iacob and Iacob. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Microbiology
Iacob, Simona
Iacob, Diana Gabriela
Infectious Threats, the Intestinal Barrier, and Its Trojan Horse: Dysbiosis
title Infectious Threats, the Intestinal Barrier, and Its Trojan Horse: Dysbiosis
title_full Infectious Threats, the Intestinal Barrier, and Its Trojan Horse: Dysbiosis
title_fullStr Infectious Threats, the Intestinal Barrier, and Its Trojan Horse: Dysbiosis
title_full_unstemmed Infectious Threats, the Intestinal Barrier, and Its Trojan Horse: Dysbiosis
title_short Infectious Threats, the Intestinal Barrier, and Its Trojan Horse: Dysbiosis
title_sort infectious threats, the intestinal barrier, and its trojan horse: dysbiosis
topic Microbiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6692454/
https://www.ncbi.nlm.nih.gov/pubmed/31447793
http://dx.doi.org/10.3389/fmicb.2019.01676
work_keys_str_mv AT iacobsimona infectiousthreatstheintestinalbarrieranditstrojanhorsedysbiosis
AT iacobdianagabriela infectiousthreatstheintestinalbarrieranditstrojanhorsedysbiosis